• Prostatic Acid Phosphatase (PAP)
  • Kappa and Lambda Free Light Chains, Quantitative, Serum
  • Hereditary Hearing Loss Gene Panel
  • Apolipoprotein A-II (APOA2) Gene Analysis
  • Secobarbital, Serum
  • Hypertrophic Cardiomyopathy Gene Mutation Panel, NGS
  • Abdominal aortic aneurysm
  • Biopsy, Endomyocardial
  • Complete Urinalysis
  • C4d Complement Activation Fragment, Plasma
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
Medical Test

Additional Testing
Access to Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis is restricted.
Loading...